IL6 and Miyoshi myopathy: This factor increasesthe activity of interleukin-6 (IL-6), a growth andsurvival factor in MM, and plays an important rolein angiogenesis by stimulating secretion of vascularendothelial growth factor (VEGF) through the MEK/ERK pathway in myeloma cells (52, 55-58).